Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.830
+0.070 (3.98%)
At close: Aug 3, 2026, 4:00 PM EDT
1.850
+0.020 (1.09%)
After-hours: Aug 3, 2026, 7:55 PM EDT
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $46.15 million as of August 3, 2026. Its market cap has decreased by -85.95% in one year.
Market Cap
46.15M
Enterprise Value
n/a
1-Year Change
-85.95%
Ranking
Category
Stock Price
$1.83
ChartMarket Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $46.15M, a decrease of -85.36%. That is a compound annual growth rate of -64.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 46.15M | -86.32% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 48.29M |
| aTyr Pharma | 47.62M |
| Immutep | 47.59M |
| BeyondSpring | 47.29M |
| Seres Therapeutics | 46.77M |
| INmune Bio | 46.52M |
| Impact BioMedical | 46.36M |
| Edesa Biotech | 45.44M |